GLP-1 injections are performed with a very small needle, and you should experience mild or no discomfort
Food and Drug Administration is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies, including Hims & Hers and other compounding pharmacies, as similar alternatives to FDA-approved drugs. The agency said the actions are intended to safeguard consumers from drugs for which the FDA cannot verify quality, safety, or efficacy. The agency also emphasized ongoing concerns around promotional claims and direct-to-consumer messaging, building on the The FDA is also taking steps to combat misleading direct-to-consumer advertising and marketing following warning letters that were sent in the fall of 2025, the agency said
Raised levels (or standard levels) with B12 supplementation is not a valid marker
Comparison of the compositions of the stool microbiotas of infants fed goat milk formula, cow milk-based formula, or breast milk
Diagnosis and management of iron deficiency anemia in inflammatory bowel disease
Studies assessing adherence behaviours in diabetes and its determinants concluded that high adherence was associated with better glycemic control [10, 11] and fewer need of hospital admissions and department visits and also lower overall costs [11]
